3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
5
Rhabdoid Tumor
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Glioma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Osteosarcoma
4
Central Nervous System Neoplasms
4
Sarcoma, Ewing
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Pancreatic Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Non functioning pancreatic endocrine tumor
1
Neoplasm Metastasis
1
Lymphoma, B-Cell
1
Lymphoma
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Carcinoma, Non-Small-Cell Lung
1
Adenoma, Islet Cell
1
Interventions
Trastuzumab
243
Paclitaxel
193
Cyclophosphamide
158
Docetaxel
134
Letrozole
113
Capecitabine
113
Fulvestrant
106
Doxorubicin
103
Bevacizumab
87
Carboplatin
81
exemestane
80
Anastrozole
79
Lapatinib
70
Tamoxifen
69
Albumin-Bound Paclitaxel
57
palbociclib
54
pertuzumab
53
Taxes
51
Gemcitabine
50
Radiotherapy
46
eribulin
43
pembrolizumab
41
Everolimus
41
Ado-Trastuzumab Emtansine
41
Vinorelbine
38
130-nm albumin-bound paclitaxel
35
ixabepilone
32
Epirubicin
28
pegfilgrastim
25
liposomal doxorubicin
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms
×
Phantoms, Imaging
×
Clear all
No trials found.